{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:23:30Z","timestamp":1786659810174,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"DOI":"10.7759\/cureus.68225","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T16:18:20Z","timestamp":1725034700000},"source":"Crossref","is-referenced-by-count":3,"title":["Advances in Pediatric Obsessive-Compulsive Disorder (OCD) Treatment: A Comprehensive Narrative Review"],"prefix":"10.7759","author":[{"given":"Ladan","family":"Khomami Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_524_18","article-title":"Challenges in the diagnosis and treatment of pediatric obsessive-compulsive disorder","volume":"61","author":"Westwell-Roper C","year":"2019","unstructured":"Westwell-Roper C, Stewart SE. Challenges in the diagnosis and treatment of pediatric obsessive-compulsive disorder. Indian J Psychiatry. 2019, 61:119-30. 10.4103\/psychiatry.IndianJPsychiatry_524_18","journal-title":"Indian J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180813155017","article-title":"Psychopharmacological treatment of obsessive-compulsive disorder (OCD)","volume":"17","author":"Del Casale A","year":"2019","unstructured":"Del Casale A, Sorice S, Padovano A, et al.. Psychopharmacological treatment of obsessive-compulsive disorder (OCD). Curr Neuropharmacol. 2019, 17:710-36. 10.2174\/1570159X16666180813155017","journal-title":"Curr Neuropharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2020_195","article-title":"On the development of OCD","volume":"49","author":"Hauser TU","year":"2021","unstructured":"Hauser TU. On the development of OCD. Curr Top Behav Neurosci. 2021, 49:17-30. 10.1007\/7854_2020_195","journal-title":"Curr Top Behav Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/15374416.2013.804386","article-title":"Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder","volume":"43","author":"Freeman J","year":"2014","unstructured":"Freeman J, Garcia A, Frank H, Benito K, Conelea C, Walther M, Edmunds J. Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2014, 43:7-26. 10.1080\/15374416.2013.804386","journal-title":"J Clin Child Adolesc Psychol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/da.20859","article-title":"Etiology of obsessive-compulsive symptoms and obsessive-compulsive personality traits: common genes, mostly different environments","volume":"28","author":"Taylor S","year":"2011","unstructured":"Taylor S, Asmundson GJ, Jang KL. Etiology of obsessive-compulsive symptoms and obsessive-compulsive personality traits: common genes, mostly different environments. Depress Anxiety. 2011, 28:863-9. 10.1002\/da.20859","journal-title":"Depress Anxiety"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10567-023-00439-2","article-title":"Closing the gap for children with OCD: a staged-care model of cognitive behavioural therapy with exposure and response prevention","volume":"26","author":"Farrell LJ","year":"2023","unstructured":"Farrell LJ, Waters AM, Storch EA, et al.. Closing the gap for children with OCD: a staged-care model of cognitive behavioural therapy with exposure and response prevention. Clin Child Fam Psychol Rev. 2023, 26:642-64. 10.1007\/s10567-023-00439-2","journal-title":"Clin Child Fam Psychol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.01.015","article-title":"The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: views based on a systematic review and meta-analysis","volume":"227","author":"Ivarsson T","year":"2015","unstructured":"Ivarsson T, Skarphedinsson G, Korn\u00f8r H, et al.. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: views based on a systematic review and meta-analysis. Psychiatry Res. 2015, 227:93-103. 10.1016\/j.psychres.2015.01.015","journal-title":"Psychiatry Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","year":"2004","unstructured":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004, 292:1969-76. 10.1001\/jama.292.16.1969","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-014-0613-0","article-title":"Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial","volume":"24","author":"Skarphedinsson G","year":"2015","unstructured":"Skarphedinsson G, Weidle B, Thomsen PH, et al.. Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial. Eur Child Adolesc Psychiatry. 2015, 24:591-602. 10.1007\/s00787-014-0613-0","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2014.05.002","article-title":"Cognitive behavior therapy for obsessive-compulsive and related disorders","volume":"37","author":"Lewin AB","year":"2014","unstructured":"Lewin AB, Wu MS, McGuire JF, Storch EA. Cognitive behavior therapy for obsessive-compulsive and related disorders. Psychiatr Clin North Am. 2014, 37:415-45. 10.1016\/j.psc.2014.05.002","journal-title":"Psychiatr Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221138092","article-title":"N-acetylcysteine for obsessive-compulsive and related disorders in children and adolescents: a review","volume":"57","author":"Parli GM","year":"2023","unstructured":"Parli GM, Gales MA, Gales BJ. N-acetylcysteine for obsessive-compulsive and related disorders in children and adolescents: a review. Ann Pharmacother. 2023, 57:847-54. 10.1177\/10600280221138092","journal-title":"Ann Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2015.13.1.12","article-title":"N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review","volume":"13","author":"Oliver G","year":"2015","unstructured":"Oliver G, Dean O, Camfield D, Blair-West S, Ng C, Berk M, Sarris J. N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. Clin Psychopharmacol Neurosci. 2015, 13:12-24. 10.9758\/cpn.2015.13.1.12","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37833","article-title":"Clinical effectiveness of N-methyl-D-aspartate (NMDA) receptor antagonists in adult obsessive-compulsive disorder (OCD) treatment: a systematic review","volume":"15","author":"Ferguson AA","year":"2023","unstructured":"Ferguson AA, Khan AI, Abuzainah B, et al.. Clinical effectiveness of N-methyl-D-aspartate (NMDA) receptor antagonists in adult obsessive-compulsive disorder (OCD) treatment: a systematic review. Cureus. 2023, 15:e37833. 10.7759\/cureus.37833","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2012.10.006","article-title":"Deep brain stimulation in the treatment of obsessive-compulsive disorder","volume":"80","author":"Blomstedt P","year":"2013","unstructured":"Blomstedt P, Sj\u00f6berg RL, Hansson M, Bodlund O, Hariz MI. Deep brain stimulation in the treatment of obsessive-compulsive disorder. World Neurosurg. 2013, 80:e245-53. 10.1016\/j.wneu.2012.10.006","journal-title":"World Neurosurg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0041","article-title":"Sertraline treatment of nonresponders to extended cognitive-behavior therapy in pediatric obsessive-compulsive disorder","volume":"25","author":"Skarphedinsson G","year":"2015","unstructured":"Skarphedinsson G, Weidle B, Ivarsson T. Sertraline treatment of nonresponders to extended cognitive-behavior therapy in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2015, 25:574-9. 10.1089\/cap.2015.0041","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder","volume":"55","author":"Varigonda AL","year":"2016","unstructured":"Varigonda AL, Jakubovski E, Bloch MH. Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2016, 55:851-9.e2. 10.1016\/j.jaac.2016.07.768","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2019.0041","article-title":"N-acetylcysteine for pediatric obsessive-compulsive disorder: a small pilot study","volume":"30","author":"Li F","year":"2020","unstructured":"Li F, Welling MC, Johnson JA, et al.. N-acetylcysteine for pediatric obsessive-compulsive disorder: a small pilot study. J Child Adolesc Psychopharmacol. 2020, 30:32-7. 10.1089\/cap.2019.0041","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.12659\/msm.895481","article-title":"Efficacy of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder: a meta-analysis","volume":"22","author":"Wu Y","year":"2016","unstructured":"Wu Y, Lang Z, Zhang H. Efficacy of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder: a meta-analysis. Med Sci Monit. 2016, 22:1646-53. 10.12659\/msm.895481","journal-title":"Med Sci Monit"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1017\/sjp.2015.22","article-title":"Psychological treatment of obsessive-compulsive disorder in children and adolescents: a meta-analysis","volume":"18","author":"Rosa-Alc\u00e1zar AI","year":"2015","unstructured":"Rosa-Alc\u00e1zar AI, S\u00e1nchez-Meca J, Rosa-Alc\u00e1zar \u00c1, Iniesta-Sep\u00falveda M, Olivares-Rodr\u00edguez J, Parada-Navas JL. Psychological treatment of obsessive-compulsive disorder in children and adolescents: a meta-analysis. Span J Psychol. 2015, 18:E20. 10.1017\/sjp.2015.22","journal-title":"Span J Psychol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100773","article-title":"Internet-delivered cognitive behavior therapy for adolescents with obsessive-compulsive disorder: an open trial","volume":"9","author":"Lenhard F","year":"2014","unstructured":"Lenhard F, Vigerland S, Andersson E, et al.. Internet-delivered cognitive behavior therapy for adolescents with obsessive-compulsive disorder: an open trial. PLoS One. 2014, 9:e100773. 10.1371\/journal.pone.0100773","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-019-1166-6","article-title":"Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review","volume":"8","author":"Babiano-Espinosa L","year":"2019","unstructured":"Babiano-Espinosa L, Wolters LH, Weidle B, Op de Beek V, Pedersen SA, Compton S, Skokauskas N. Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review. Syst Rev. 2019, 8:284. 10.1186\/s13643-019-1166-6","journal-title":"Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.170","article-title":"Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr): a randomized clinical trial","volume":"71","author":"Freeman J","year":"2014","unstructured":"Freeman J, Sapyta J, Garcia A, et al.. Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr): a randomized clinical trial. JAMA Psychiatry. 2014, 71:689-98. 10.1001\/jamapsychiatry.2014.170","journal-title":"JAMA Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2023.0018","article-title":"What is the added benefit of combining cognitive behavioral therapy and selective serotonin reuptake inhibitors in youth with obsessive compulsive disorder? A Bayesian hierarchical modeling meta-analysis","volume":"33","author":"Mendez EM","year":"2023","unstructured":"Mendez EM, Dahlsgaard KK, Hjelmgren JM, Mills JA, Suresh V, Strawn JR. What is the added benefit of combining cognitive behavioral therapy and selective serotonin reuptake inhibitors in youth with obsessive compulsive disorder? A Bayesian hierarchical modeling meta-analysis. J Child Adolesc Psychopharmacol. 2023, 33:203-11. 10.1089\/cap.2023.0018","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.17992\/lbl.2016.04.75","article-title":"A review and recommendations of evidence-based treatments for pediatric obsessive-compulsive disorder. (Article in Icelandic)","volume":"102","author":"Skarphedinsson G","year":"2016","unstructured":"Skarphedinsson G, Lauth B, Njardvik U, Ivarsson T. A review and recommendations of evidence-based treatments for pediatric obsessive-compulsive disorder. (Article in Icelandic). Laeknabladid. 2016, 102:179-85. 10.17992\/lbl.2016.04.75","journal-title":"Laeknabladid"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2013.09.007","article-title":"Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder","volume":"51","author":"Storch EA","year":"2013","unstructured":"Storch EA, Bussing R, Small BJ, et al.. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013, 51:823-9. 10.1016\/j.brat.2013.09.007","journal-title":"Behav Res Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13934","article-title":"Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis","volume":"65","author":"Cervin M","year":"2024","unstructured":"Cervin M, McGuire JF, D'Souza JM, et al.. Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis. J Child Psychol Psychiatry. 2024, 65:594-609. 10.1111\/jcpp.13934","journal-title":"J Child Psychol Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.1128","article-title":"Efficacy of augmentation of cognitive behavior therapy with weight-adjusted D-cycloserine vs placebo in pediatric obsessive-compulsive disorder: a randomized clinical trial","volume":"73","author":"Storch EA","year":"2016","unstructured":"Storch EA, Wilhelm S, Sprich S, et al.. Efficacy of augmentation of cognitive behavior therapy with weight-adjusted D-cycloserine vs placebo in pediatric obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry. 2016, 73:779-88. 10.1001\/jamapsychiatry.2016.1128","journal-title":"JAMA Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/da.22132","article-title":"Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy","volume":"30","author":"Farrell LJ","year":"2013","unstructured":"Farrell LJ, Waters AM, Boschen MJ, et al.. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy. Depress Anxiety. 2013, 30:723-31. 10.1002\/da.22132","journal-title":"Depress Anxiety"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221060-advances-in-pediatric-obsessive-compulsive-disorder-ocd-treatment-a-comprehensive-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T16:18:24Z","timestamp":1725034704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221060-advances-in-pediatric-obsessive-compulsive-disorder-ocd-treatment-a-comprehensive-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.68225","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}